New Perspectives for Staging and Prognosis in Soft Tissue Sarcoma

By Lahat G.  

Annals of Surgical Oncology, Vol. 15, Iss. 10, 2008-10 ,pp. : 2739-2748

Springer Publishing Company

Access to resources Recommend Favorite

Endometrial Stromal Sarcoma: Etiology, Prognosis and Treatment Options

By Maluf F.C.  

American Journal of Cancer, Vol. 3, Iss. 1, 2004-01 ,pp. : 13-23

Adis International

Access to resources Recommend Favorite

A unique radiation scheme for the treatment of high-grade non-metastatic soft tissue sarcoma: The Detroit Medical Center experience

By Fontanesi James  

Sarcoma, Vol. 9, Iss. 3-4, 2005-09 ,pp. : 141-145

Informa Healthcare

Access to resources Recommend Favorite

Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 400-402

Science Publishers

Access to resources Recommend Favorite

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite